Drug development is typically slow: the pipeline from basic research discoveries that provide the basis for a new drug to clinical trials to production of a widely available medicine can take decades. But decades can feel ...
Jun 27, 2024
1
19
Withanolides, a class of naturally occurring compounds found in plants, have long been a focus of cancer research due to their ability to inhibit cancer cell growth, induce cell death and prevent metastasis. These compounds ...
Jun 28, 2024
0
36
Researchers at the National Institutes of Health (NIH) have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer ...
Jun 19, 2024
0
35
Psilocybin mushrooms are the psychedelic substance most often used in the U.S., with its popularity outpacing other psychedelic drugs such as MDMA (known as ecstasy), according to a new RAND report.
Jun 27, 2024
0
6
Researchers at Purdue University's College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute myeloid leukemia (AML). AML is a cancer that begins in bone marrow and sometimes metastasizes ...
Jun 21, 2024
0
6
An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery lived significantly longer and ...
Jun 18, 2024
0
1
University of Oxford researchers have leveraged the power of artificial intelligence (AI) to develop personalized cancer treatments which could be more effective at preventing patient relapse.
Jun 17, 2024
0
3
Americans' interest in a potentially harmful "magic mushroom" is soaring, with Google searches skyrocketing 114% from 2022 to 2023, according to a new study by researchers at the University of California San Diego Herbert ...
Jun 11, 2024
0
1
Underrepresented populations have been historically excluded from clinical trials including women, racial and ethnic minority groups, and pregnant, lactating, pediatric and geriatric populations. While the importance of including ...
Jun 26, 2024
0
0
The US Food and Drug Administration (FDA) tells staff leaving for industry jobs that, despite restrictions on post-employment lobbying, they are still permitted to influence the agency, reveals an investigation by The BMJ.
Jul 1, 2024
0
0
